PROSTAGLANDIN DYNAMICS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND LESIONS OF THE STOMACH MUCOSA (7-9)

DOI:

Дата публикации статьи в журнале: 2019/04/21

Название журнала: Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале, Выпуск: 60, Том: 1, Страницы в выпуске: 7-9

Автор: Piddubna А.A.
Candidat of medical sciences, Department of Clinical Immunology, Allergology and Endocrinology Bukovinian State Medical University ,

Автор: Vivsiannyk V.V.
Candidate of Medical Sciences, Assistant , Bukovinian State Medical University Internal Medicine Department ,

Автор: Fedoruk V.O.
Student, Bukovinian State Medical University ,

Анотация: Today it is known that prostaglandins (PG), including PgE2,PgI2, are able to contribute to the rehabilitation of damaged gastric mucosa (GM) that positively influence on the morphological changes, regression of rebuilding changes, the proliferative activity of epithelial cells and the depth of occurrence of Helicobacter pylori (HP)- simultaneously affect several elements of pathogenesis [1,6,7,12,13].

Ключевые слова: PROSTAGLANDIN, DYNAMICS,

Данные для цитирования: Piddubna А.A. Vivsiannyk V.V. Fedoruk V.O. . PROSTAGLANDIN DYNAMICS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND LESIONS OF THE STOMACH MUCOSA (7-9) // Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале. Медицинские науки. 2019/04/21; 60(1):7-9.

Скачать в формате PDF

Список литературы: 1. A.Terano. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, doubleblind, placebo-controlled trial / A.Terano, T.Arakawa, T.Sugiyama [et al.] // Journal of Gastoenterology. – 2007. – Vol.42, №8. – P.690-693. 2. Annuk M. Oxidative stress markers in preuremic patients.// Clin. Nephrol.- 2005.- Vol. 56, // Fellstrom B., Akerblom O // №4.- P. 308-314. 3. Avramenko A.A. Ulcer disease (Essays on the clinical pathophysiology) / A.A.Avramenko, A.I.Gozhenko, V.S.Goydyk. - Odessa, 2008. - 304 p. 4. Jan Galle. Oxidative stress in chronic renal failure // Nephr. Dialysis Transplant. – 2005. – Vol. 16, N 11. – P. 2135–2137. 5. K.Tokuhara. Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes / K.Tokuhara, Y.Hamada, H.Tanaka [et al.] // Nitric Oxide. – 2008. – Vol.18, №1. – P.28-36. 6. Kim Р.К. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers / [Kim H.K., Kim J.L., Kim J.K. et al.] // Dig. Dis. Sci. – 2007. – Vol.52, N8. – P.1776-1782. 7. Kobayashi Т. Suppressive effect of Rebamipide, an antiulcer agent, against activation of human neutrophils exposed to formyl-methionyl-leucylphenylalanine / T.Kobayashi, V.S.Zinchuk, E.GarciadelSaz [et al.] // Histology and Histopathology. – 2009. – Vol.15, №4. – P.1067-1076. 8. Mehnert-Kay S.A. Diagnosis and Management of Uncoplicated Urinary Tract Infections // Amer Fam Phys. – 2005, Aug 1. – V. 72, N 3. – Р. 451-456. 9. Modern gastroenterology.-2007.-N2. Features of morphological state of the gastric mucosa in patients with duodenal ulcer depending on the presence of pathogenicity of H. Pylori. Main editor Babak O.- professional journal VAK Ukraine / Academy of Medical Sciences of Ukraine, Institute of Gastroenterology AMS of Ukraine.-K.: Ltd"WIT-APOL" 01.01.2007. 10. Moiseenko V.O. Gastrointestinal disorders in patients with secondary nephropathies // V.O. Moiseenko Actual problems of Nephrology (Vol. 6) / Ed. T.D. Nykula. - K .: Zadruha, 2006. - S. 236-238. 11. Resolution of 2 nd Congress of nephrologists of Ukraine (Kharkiv, 24 September 2005) // Ukr. j. nephrology and dialysis. - 2005. - № 4. - P. 2-5. 12. Yakovenko E. The state of gastro-esophageal mucosa and Helicobacter pylori infection in chronic renal insufficiency patients after kidney transplantation/ E. Yakovenko, V.Anashkin, A. Ivanov et al. // Helicobacter. – 2005. – Vol. 10 – P. 515. 13. Zub l.O. Pathogenetic substantiation of correction of treatment of patients with chronic kidney disease stage II-III with the presence of lesions of the gastroduodenal area // L.O. Zub, O.I. Fediv, V.V. Vivsyannyk [et al.] // Galyzkiiy medical Journal. - 2009. - №3. - P. 111-115. 14. Н. Murata. Gastro-protective agent rebamipide induces cyclooxygenase-2 (COX-2) in gastric epithelial cells / Murata H., Yabe Y., Tsuji S. [et al.] // Digestive Diseases and Sciences. – 2009. – Vol.50, Suppl.1. – P.70-75. 15. Т. Tanigawa. Rebamipide inhibits gastric cancer cell growth / T.Tanigawa, R.Pai, T.Arakawa [et al.] // Digestive Diseases and Sciences. – 2007. – Vol.52, №1. – P.240-247.